Shanghai Fosun Pharmaceutical (Group) Co., Ltd.:企業のM&A・事業提携・投資動向

◆英語タイトル:Shanghai Fosun Pharmaceutical (Group) Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2119
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:101
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Shanghai Fosun Pharmaceutical (Group) Co., Ltd. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Shanghai Fosun Pharmaceutical (Group) Co., Ltd.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 36
Corporate Venturing – Overview 36
Corporate Venturing – Deal reports 37
PARTNERSHIP 49
Partnership – Overview 49
Partnership – Deal reports 50
CAPITAL RAISING 69
Capital Raising – Overview 69
Capital Raising – Deal reports 70
DIVESTMENTS 79
Divestments – Overview 79
Divestments – Deal reports 80
APPENDIX 90
Contact Us 90
About MarketLine Financial Deals Database 90
Deal Definition and Methodology 92
About MarketLine 99

List of Tables
Table 1: Shanghai Fosun Pharmaceutical (Group) Co. M&A volume and value trend (2014-YTD2018)
Table 2: Shanghai Fosun Pharmaceutical (Group) Co. M&A activity by geography (2014-YTD2018)
Table 3: Shanghai Fosun Pharmaceutical (Group) Co. corporate venturing volume and value trend (2014-YTD2018)
Table 4: Shanghai Fosun Pharmaceutical (Group) Co. corporate venturing by geography (2014-YTD2018)
Table 5: Shanghai Fosun Pharmaceutical (Group) Co. partnership volume and value trend (2014-YTD2018)
Table 6: Shanghai Fosun Pharmaceutical (Group) Co. partnership trend by key deal type (2014-YTD2018)
Table 7: Shanghai Fosun Pharmaceutical (Group) Co. capital raising volume and value trend (2014-YTD2018)
Table 8: Shanghai Fosun Pharmaceutical (Group) Co. capital raising by deal type (2014-YTD2018)
Table 9: Shanghai Fosun Pharmaceutical (Group) Co. divestments volume and value trend (2014-YTD2018)
Table 10: Shanghai Fosun Pharmaceutical (Group) Co. divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Shanghai Fosun Pharmaceutical (Group) Co. M&A volume and value trend (2014-YTD2018)
Figure 2: Shanghai Fosun Pharmaceutical (Group) Co. M&A activity by geography (2014-YTD2018)
Figure 3: Shanghai Fosun Pharmaceutical (Group) Co. corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Shanghai Fosun Pharmaceutical (Group) Co. corporate venturing by geography (2014-YTD2018)
Figure 5: Shanghai Fosun Pharmaceutical (Group) Co. partnership volume and value trend (2014-YTD2018)
Figure 6: Shanghai Fosun Pharmaceutical (Group) Co. partnership trend by key deal type (2014-YTD2018)
Figure 7: Shanghai Fosun Pharmaceutical (Group) Co. capital raising volume and value trend (2014-YTD2018)
Figure 8: Shanghai Fosun Pharmaceutical (Group) Co. capital raising by deal type (2014-YTD2018)
Figure 9: Shanghai Fosun Pharmaceutical (Group) Co. divestments volume and value trend (2014-YTD2018)
Figure 10: Shanghai Fosun Pharmaceutical (Group) Co. divestments by geography (2014-YTD2018)

★海外企業調査レポート[Shanghai Fosun Pharmaceutical (Group) Co., Ltd.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Quebecor Inc (QBR.B):企業の財務・戦略的SWOT分析
    Quebecor Inc (QBR.B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • MasTec Inc (MTZ):企業の財務・戦略的SWOT分析
    MasTec Inc (MTZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • PBF Energy Inc. (PBF)-石油・ガス分野:企業M&A・提携分析
    Summary PBF Energy Inc. (PBF Energy) is an independent oil refining company. It owns and operates crude oil refineries and related facilities in the US. Its refining assets include Delaware City refinery, Delaware; Paulsboro refinery, New Jersey; Chalmette refinery, Louisiana, Torrance, California a …
  • Express Scripts Holding Co (ESRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Express Scripts Holding Company (Express Scripts) is a pharmacy benefit management (PBM) company. It provides integrated pharmacy-benefit management services such as home delivery pharmacy services, specialty benefit management, network-pharmacy claims processing, formulary management, and m …
  • MagForce AG (MF6):企業の財務・戦略的SWOT分析
    Summary MagForce AG (MagForce) is a medical device company that offers nanotechnology-based therapy for cancer treatment. The company’s products include NanoActivator, NanoTherm, NanoPlan and NanoTherm Therapy. Its NanoActivator creates a magnetic field that can be used to treat tumors in all areas …
  • United Therapeutics Corp (UTHR):企業の財務・戦略的SWOT分析
    United Therapeutics Corp (UTHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Option Care Enterprises Inc:企業の戦略的SWOT分析
    Option Care Enterprises Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Arabtec Holding:企業の戦略・SWOT・財務情報
    Arabtec Holding - Strategy, SWOT and Corporate Finance Report Summary Arabtec Holding - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Jakks Pacific, Inc.:企業の戦略・SWOT・財務分析
    Jakks Pacific, Inc. - Strategy, SWOT and Corporate Finance Report Summary Jakks Pacific, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ctrip.Com International Ltd:企業の戦略・SWOT・財務分析
    Ctrip.Com International Ltd - Strategy, SWOT and Corporate Finance Report Summary Ctrip.Com International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • MetaStat Inc (MTST):製薬・医療:M&Aディール及び事業提携情報
    Summary MetaStat Inc (MetaStat) is a biotechnology company that discovers and develops personalized diagnostic and therapeutic treatment solutions for cancer patients. The company develops therapeutic product candidates based on novel approach that offers intracellular Mena protein isoforms drugable …
  • Taiwan High Speed Rail Corporation:企業の戦略・SWOT・財務分析
    Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Housing Development Finance Corporation Limited:戦略・SWOT・企業財務分析
    Housing Development Finance Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Housing Development Finance Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Checkmate Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Checkmate Pharmaceuticals Inc (Checkmate Pharmaceuticals) is a clinical stage company that discovers and develops immunotherapies to provide new treatment options for patients and the healthcare providers. The company’s lead product candidate, CMP-001, is a CpG oligonucleotides (CpG-A ODN) t …
  • Wolters Kluwer N.V. (WKL):企業の財務・戦略的SWOT分析
    Wolters Kluwer N.V. (WKL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sigma Pharmaceuticals Limited:企業の戦略・SWOT・財務情報
    Sigma Pharmaceuticals Limited - Strategy, SWOT and Corporate Finance Report Summary Sigma Pharmaceuticals Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Norwegian Cruise Line Holdings Ltd. (NCLH):企業の財務・戦略的SWOT分析
    Norwegian Cruise Line Holdings Ltd. (NCLH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Northern Biologics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Northern Biologics Inc. (Northern Biologics) is a biotech company, which develops a portfolio of antibody therapies for treating cancer. The product pipeline of the company includes MSC-1, a first-in-class antibody that acts against leukemia inhibitory factor (LIF), which is a major immunosu …
  • Enercon Services Inc:企業の戦略的SWOT分析
    Enercon Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Ethicon US LLC:製品パイプライン分析
    Summary Ethicon US LLC (Ethicon), a subsidiary of Johnson and Johnson, is a medical equipment company which operates through Ethicon Inc, and Ethicon Endo-Surgery Inc. It develops and markets surgical instruments and devices. Its major products include staplers, energy devices, clip appliers, trocar …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆